Zimmer Inventory from 2010 to 2025

ZBH Stock  USD 104.83  1.20  1.16%   
Zimmer Biomet's Inventory is increasing with slightly volatile movements from year to year. Inventory is estimated to finish at about 2.9 B this year. For the period between 2010 and 2025, Zimmer Biomet, Inventory quarterly trend regression had mean deviation of  634,862,852 and range of 2.7 B. View All Fundamentals
 
Inventory  
First Reported
2000-12-31
Previous Quarter
2.4 B
Current Value
2.2 B
Quarterly Volatility
807.8 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 B, Interest Expense of 141.5 M or Selling General Administrative of 2 B, as well as many indicators such as Price To Sales Ratio of 11.09, Ptb Ratio of 2.22 or Capex To Depreciation of 0.81. Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
  
Check out the analysis of Zimmer Biomet Correlation against competitors.

Latest Zimmer Biomet's Inventory Growth Pattern

Below is the plot of the Inventory of Zimmer Biomet Holdings over the last few years. It is Zimmer Biomet's Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zimmer Biomet's overall financial position and show how it may be relating to other accounts over time.
Inventory10 Years Trend
Slightly volatile
   Inventory   
2.4B2.5B2.1B2.1B2.4B2.7B2.9B3%-12%11%15%5%100%
       Timeline  

Zimmer Inventory Regression Statistics

Arithmetic Mean1,879,500,562
Geometric Mean1,602,428,585
Coefficient Of Variation41.05
Mean Deviation634,862,852
Median2,148,000,000
Standard Deviation771,553,489
Sample Variance595294.8T
Range2.7B
R-Value0.89
Mean Square Error128639.3T
R-Squared0.80
Slope144,796,728
Total Sum of Squares8929421.8T

Zimmer Inventory History

20252.9 B
20242.7 B
20232.4 B
20222.1 B
20212.1 B
20202.5 B
20192.4 B

Other Fundumenentals of Zimmer Biomet Holdings

About Zimmer Biomet Financial Statements

Investors use fundamental indicators, such as Zimmer Biomet's Inventory, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Inventory2.7 B2.9 B
Change To Inventory-216.4 M-205.5 M
Inventory Turnover 1.00  1.29 
Days Of Inventory On Hand 376.01  261.70 
Days Of Inventory Outstanding 376.01  261.70 

Currently Active Assets on Macroaxis

When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:
Check out the analysis of Zimmer Biomet Correlation against competitors.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.40)
Dividend Share
0.96
Earnings Share
4.43
Revenue Per Share
37.807
Quarterly Revenue Growth
0.043
The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
News Freq…Investor S…100%